Cambridgeshire Council Approves Prologis Partnership for Biomedical Campus Expansion

On 5 February 2026, Cambridgeshire County Council’s Assets and Procurement Committee approved a development partnership with Prologis to expand the Cambridge Biomedical Campus using council-owned land.

This decision is intended to support further growth of the campus, which is already home to several major research and healthcare institutions and contributes substantially to the local economy.

The approved agreement allows Prologis UK Ltd to obtain an option for a long leasehold on 67 acres of council land, subject to securing planning permission for the proposed expansion. The council’s action is expected to facilitate the next phases of the campus’s development, with a focus on creating new research and innovation facilities.

Phases 3 and 4 of the expansion are projected to provide up to 2.4 million square feet of space dedicated to life science research, development, and innovation. The plans include an innovation hub, co-working laboratories, learning areas, a skills and training centre, serviced apartments for keyworkers, and offices for companies supporting the life sciences sector.

What the numbers show

• Up to £3 billion in private investment is anticipated over 20 years
• Phases 3 and 4 are set to deliver up to 2.4 million square feet of new space
• The campus currently supports over 22,000 jobs and generates about £4.2 billion in gross value added annually
• A £4 million community investment fund is included in the proposals

The expansion project also proposes a £4 million community-focused fund to support local initiatives and deliver social value. Plans for the site include new transport infrastructure, green spaces, and a community fund to benefit the surrounding area.

Institutions already located at Cambridge Biomedical Campus include AstraZeneca’s global headquarters, Cambridge University Hospitals NHS Foundation Trust, the Wellcome Trust, and Cancer Research UK. These organizations contribute to the campus’s role as a centre for research, healthcare, and innovation in the region.

According to published figures, the campus currently generates approximately £4.2 billion in gross value added each year. It also provides employment for more than 22,000 people, reflecting its economic significance for Cambridgeshire and the wider area.

The council’s approval of the partnership with Prologis is conditional on obtaining planning consent for the expansion. The proposed developments are designed to support both the scientific community and local residents through new facilities and investment in community resources.

* This article is based on publicly available information at the time of writing.